Transurethral Bipolar Plasmakinetic Resection of the Prostate for the Treatment of Benign Prostatic Hyperplasia

Objective:To evaluate the safety and efficacy of transurethral bipolar plasmakinetic resection of the prostate(TUPKRP)for the treatment of benign prostatic hyperplasia(BPH).Method: 226 cases of benign prostatic hyperplasia were treated with transurethral bipolar plasmakinetic resection of the prostate.Result : The duration of the procedure was 35～190(65±43)min.No obturator reflex or transurethral resection syndrome occurred and the blood loss was low during operation.226 patients had been followed up for 6 to 12 months,and the international prostate symptom score(IPSS)decreased from(23.7±6.2) preoperatively to(14.2±5.8) postoperatively.The scores of quality of life(QOL)decreased from(4.2±0.8) preoperatively to(1.5±0.2)postoperatively.The residual urine volume(RUV) decreased from(98±81)ml preoperatively to(16±8)ml postoperatively.3 cases of external urethral stricture and no cases of posterior urethral stricture and no cases of permanent incontinence of urine were found.Conclusion:Transurethral bipolar plasmakinetic resection of the prostate for the treatment of benign prostatic hyperplasia is effective and safe with few complications and general indications.